Skip to content

Urgent urology symptoms What to do

FDA fails to approve cholesterol drug for kidney disease

Urology TodayPublished January 25, 20122 min read

Key points

  • U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.
  • Merck had asked the Food and Drug Administration to approve the new indication, and the company relayed the agency’s decision on Wednesday.
  • Vytorin pairs a new type of cholesterol fighter Zetia, or ezetimibe, with Merck’s older statin drug Zocor, or simvastatin.
  • Chronic kidney disease affects about 14 percent of the U.S. population and puts people at a high risk of developing heart disease and having a stroke or heart attack.

U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.

The decision means Merck cannot market Vytorin as a treatment for reducing the rate of heart problems in kidney patients, though it can discuss the new label with doctors.

Merck had asked the Food and Drug Administration to approve the new indication, and the company relayed the agency’s decision on Wednesday.

“The final outcome is slightly disappointing, as many street observers had expected an actual new indication claim,” Mark Schoenebaum, an analyst at ISI Group, said in a report.

Vytorin pairs a new type of cholesterol fighter Zetia, or ezetimibe, with Merck’s older statin drug Zocor, or simvastatin.

Vytorin is already approved for lowering cholesterol, but the company had been hoping to expand its use to prevent stroke and other heart problems in patients with chronic kidney disease.

Chronic kidney disease affects about 14 percent of the U.S. population and puts people at a high risk of developing heart disease and having a stroke or heart attack.

The new labeling reflects the findings of the SHARP study, which showed Vytorin reduced the risk of major vascular problems in patients with moderate to severe chronic kidney disease.

It was the first randomized controlled study that showed statins can lower the rate of heart problems in kidney disease patients, Merck said.

However, because the study did not look at the individual contributions of Zetia and Zocor to the reduction in heart problems, the FDA did not approve a new indication for Vytorin or Zetia, Merck said.

Merck’s patents on both Vytorin and Zetia expire in 2017. In 2010, Vytorin posted sales of $2 billion and Zetia reaped $2.3 billion.

###

By Anna Yukhananov

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.